- Recent Contract Wins and Billing Solutions
Acquisition Provide Growth Catalysts -
TORONTO, July 28, 2016 /CNW/ - Syncordia Technologies
and Healthcare Solutions, Corp. (TSXV: SYN) ("Syncordia" or the
"Company") today reported financial results for the three and
twelve months ended March 31,
2016.
Reported results reflect twelve months of operations of Health
Services Integration Inc. ("HSI"), acquired October 31, 2014, 342 days of operations of
Paragon Billing, LLC ("Paragon") acquired April 24, 2015 and 10 days of operations of
Billing Solutions, LLC ("Billing Solutions") acquired March 22, 2016. References to 2015 and 2016
reflect the fiscal years ended March 31,
2015 and 2016 respectively. References to the first, second,
third and fourth quarter refer to the three months ended
June 30th, September 30th, December 31st and March 31st, respectively.
All results are reported in thousands of US dollars and are
prepared in accordance with International Financial Reporting
Standards ("IFRS").
We have made a significant number of operational and management
changes over the last few quarters, which we believe will be
reflected in our operating results in the future quarters. Within
our RCM segment, we are ahead of our cost per claim objectives as
shared at the Investor Day December
3rd 2015, which exceeds the operational mandate. We have
established second operational billing centers for both HSI and
Paragon to support organic growth and have made significant process
and structural changes at Billing Solutions to improve gross and
operating profit margin and service standards, since the
acquisition closing in late March. We introduced various Platform
Syncordia products at Billing Solutions and HSI, specifically Claim
Editor and Coordinet.
Additionally, between the third and fourth quarter of 2016
ending March 31, we reduced our
Corporate and Syncordia Cloud (Platform Syncordia). expenses, while
adding another acquisition, which is consistent with our previous
messaging of growing the enterprise without growing the Corporate
expenses.
We have realigned our sales organization with the closing of
Billing Solutions to more effectively align our strategic
objectives and the advancements of Platform Syncordia with our
organic growth plans. Our sales pipeline remains robust and we look
forward to welcoming new clients.
Fourth Quarter 2016 Compared to Third Quarter 2016
- Revenue from the Revenue Cycle Management ("RCM") segment was
$2,918, a 20% sequential decrease
reflecting the impact of the previously announced REACH Medical
Holdings contract termination, winter month seasonality and a less
favourable payor mix, partially offset by $167 of revenue from Billing Solutions.
- Adjusted EBITDA before Corporate and Syncordia Cloud segment
costs was $806 compared to
$1,674, reflecting lower revenue as
noted above.
- Adjusted EBITDA was negative $120
compared to $704.
- As at March 31, 2016 Cash and
cash equivalents were $4,436 compared
to $10,285 as at December 31, 2015 reflecting $5,871 to fund the acquisition of Billing
Solutions and routine capital expenditures, $306 for interest payments, $160 for transaction costs and $489 for operating activities.
2016 Financial Highlights
- Revenue was $13,888 and is
segmented by RCM business as follows - $11,901 HSI, $1,820
Paragon Billing and $167 Billing
Solutions.
- Adjusted EBITDA before Corporate and Syncordia Cloud segment
costs was $5,755.
- Adjusted EBITDA was $1,907
inclusive of $16 attributable to our
80% interest in Billing Solutions.
Business Highlights
- Completed the acquisition of an 80% interest in Billing
Solutions, LLC, a full-service third-party billing solutions
company based in Prescott,
Arizona, dedicated to the mental and behavioral health
industry.
- Secured a three year contract with Air Medical for air
ambulance RCM billing services.
- Subsequent to the fourth quarter, secured several new contracts
including:
- Multi-year contracts with Mercy Health North LLC and LACP/St
Rita's Medical Center, of Toledo,
Ohio ("Mercy") both of whom are the affiliated EMS units of
Mercy St. Vincent Medical Center for RCM services focused on
Mercy's rotary wing EMS, mobile intensive care unit.
- Five year contract with five year automatic renewals, with Jet
911 of Kew Gardens, New York, a
fixed wing air ambulance service.
- Two year contract with The Bridges Network, LLC/ Cornerstone
Recovery Center, LLC effective June 1,
2016 for an initial two year term, with automatic annual
renewals thereafter.
- Contract extension with REACH Medical Holdings, LLC ("Reach"),
a wholly owned subsidiary of Air Medical Group Holdings, Inc.
pursuant to which, HSI will continue to provide RCM services for
claims in existence at November 30,
2015 until May 31, 2017.
- Announced the implementation of our proprietary Claim Editor, a
workflow automation tool designed to minimize errors while
maximizing payment rates in submitting medical billing claims and
decreasing the time to input claims by more than 2.5 times. We also
unveiled Coordinet, a cloud-based application designed to assist
hospital systems in the coordination of care for high risk patients
with the goal of minimizing inappropriate readmissions and the
resulting associated fines from CMS (Centers for Medicare and
Medicaid).
- Hired Chief Technology Officer Andy
Tran, a 21 year veteran in the technology industry with
vertical experiences including software-as-a-service (SaaS),
print-and-fulfillment, healthcare, and financial services.
Key Performance Indicators
We report Encounters as a key performance indicator to assist
readers in better evaluating our performance. We define an
Encounter as a discrete business activity for which we would submit
a claim. We believe this metric provides investors with a better
proxy for measuring the level of business activity than revenue as
encounters measure the number of distinct services provided in the
period whereas revenue reflects the amount of services recognized
for accounting purposes and is typically a lagging indicator of
business activity.
|
|
|
|
|
|
|
|
Encounters
|
|
Sequential Quarterly
Change
|
|
Quarter
|
|
Q1
|
Q2
|
Q3
|
Q4
|
#
|
%
|
|
Total
|
Air
|
|
4,891
|
5,894
|
4,656
|
2,767
|
(1,889)
|
(41%)
|
|
18,208
|
Ground
|
|
7,648
|
9,007
|
6,908
|
5,821
|
(1,087)
|
(16%)
|
|
29,384
|
HSI
|
|
12,539
|
14,901
|
11,564
|
8,588
|
(2,976)
|
(26%)
|
|
47,592
|
Paragon
|
|
81,244
|
73,834
|
76,053
|
82,345
|
6,292
|
8%
|
|
313,476
|
Billing
Solutions(i)
|
|
-
|
-
|
-
|
50,690
|
-
|
-
|
|
50,690
|
(i) Encounters for Billing
Solutions are for the period January 1 to March 31,
2016.
|
HSI Encounters decreased 26% primarily reflecting the provision
of RCM services to REACH Medical Holdings, LLC for claims in
existence until November 30, 2015.
HSI incurred 2,864 Encounters (1,843 Air Encounters and 1,021
Ground Encounters) attributed to REACH in the third quarter of
fiscal 2016 compared to nil Encounters in the fourth quarter of
fiscal 2016.
Paragon Encounters increased 8% primarily reflecting a growth in
the number of customers in the fourth quarter of fiscal 2016.
Billing Solutions Encounters for fourth quarter of fiscal 2016
reflect a full three months of operations. Syncordia acquired an
80% interest in Billing Solutions on March
22, 2016.
Paragon Encounters for first quarter of fiscal 2016 reflect a
full three months of operations. Syncordia acquired Paragon
on April 24, 2015.
Management Commentary
"This past quarter was
transformative for Syncordia. We completed the acquisition of
Billing Solutions, a full-service third-party billing solutions
company based in Prescott,
Arizona, dedicated to the mental and behavioral health
industry to our expanding portfolio of revenue cycle management
companies. We were awarded several contracts subsequent to quarter
end which will bolster revenue growth in the coming year. We
accomplished a considerable amount this year including becoming a
reporting issuer, acquiring Billing Solutions, and strengthening
our management team. We are well positioned to execute on our
business strategy of acquiring niche revenue cycle management
companies and developing Syncordia Cloud, a suite of software as a
service solution for the healthcare industry", said Michael Franks, Chief Executive Officer.
Notice of Conference Call
Syncordia will hold a
conference call on Friday, July 29,
2016, at 8:00 a.m (ET) to discuss its financial results and
other corporate developments. To access the conference call by
telephone, dial 647-427-7450 or 1-888-231-8191. A live audio
webcast will be available through www.syncordiahealth.com or
http://event.on24.com/r.htm?e=1218947&s=1&k=FDCE3FC30DB2762E79EB29D359E50CC1.
An archived replay of the webcast will be available for 90 days. A
presentation will accompany the conference call and will be
available for download from the Investor Relations section of
Syncordia's website at:
http://www.syncordiahealth.com/company/investor-relations/events-presentations/.
Forward Looking Statements
Certain statements herein
may be "forward looking" statements that involve known and unknown
risks, uncertainties and other factors that may cause the actual
results, performance or achievements of Syncordia or the industry
to be materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements. Forward looking statements involve significant risks
and uncertainties, should not be read as guarantees of future
performance or results, and will not necessarily be accurate
indications of whether or not such results will be achieved. A
number of factors could cause actual results to vary significantly
from the results discussed in the forward looking statements. These
forward looking statements reflect current assumptions and
expectations regarding future events and operating performance and
are made as of the date hereof and we assume no obligation, except
as required by law, to update any forward looking statements to
reflect new events or circumstances.
Cautionary Note Regarding Non-IFRS Measures
This press
release contains references to "EBITDA," "Adjusted EBITDA," "Gross
margin," and "Adjusted EBITDA before Syncordia Cloud and Corporate
costs."
Earnings before Interest, Taxes, Depreciation and Amortization
("EBITDA") and Adjusted Earnings before Interest, Taxes,
Depreciation and Amortization ("Adjusted EBITDA") are non-IFRS
measures used by management to provide additional insight into our
performance and financial condition. We believe that these
non-IFRS measures are important as they provide an indication of
the results generated by our RCM business prior to taking into
consideration how those activities are financed as well as the
other items listed in their respective definitions.
Accordingly, we are presenting EBITDA, Adjusted EBITDA and Adjusted
EBITDA before Syncordia Cloud and Corporate costs in this MD&A
to enhance the usefulness of our MD&A. We have provided below a
reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA
before Syncordia Cloud Corporate costs to the most directly
comparable IFRS figures, disclosure of the purpose of the non-IFRS
measure, and how the non-IFRS measures is used in managing the
business.
EBITDA, Adjusted EBITDA and Adjusted EBITDA before Syncordia
Cloud and Corporate costs are not calculations based on IFRS and
should not be considered an alternative to operating income or net
income (loss) in measuring the our performance, nor should it be
used as an exclusive measure of cash flow, because it does not
consider the impact of working capital growth, capital
expenditures, debt principal reductions and other sources and uses
of cash which are disclosed in the consolidated statements of cash
flows. Investors should carefully consider the specific items
included in our computation of these measures.
Management defines EBITDA as Earnings before Interest, Taxes,
Depreciation and Amortization.
Management defines Adjusted EBITDA as Earnings before Interest,
Taxes, Depreciation, Amortization, Transaction Costs, Fair Value
Gains/Losses, Foreign Exchange Gains/Losses, Stock Based
Compensation and Cash based Share Compensation Arrangements.
Transaction costs include professional fees associated with
business transactions.
Management defines Adjusted EBITDA before Syncordia Cloud and
Corporate costs as Earnings before Interest, Taxes, Depreciation,
Amortization, Transaction Costs, Fair Value Gains/Losses, Foreign
Exchange Gains/Losses, Stock Based Compensation, Cash based Share
Compensation Arrangements and costs of our Syncordia Cloud and
Corporate segment. This metric is used to assess the performance of
RCM and Syncordia Cloud segments.
Gross margin is a non-IFRS measure defined by management to
reflect revenue less direct cost of sale, excluding amortization of
intellectual property, customer lists, other amortizations and fair
value gains/losses.
Syncordia Cloud and Corporate costs include sales and marketing,
general and administrative and research and development, less
amortization and depreciation, foreign exchange gains and losses,
and stock-based compensation expense indexed to our share
price.
About Syncordia Technologies and Healthcare Solutions,
Corp.
We are a technology enhanced revenue cycle management
("RCM") company focused on underserved niche segments of the
healthcare industry. We are building a diversified software and
services business by consolidating healthcare billing providers.
Our growth strategy is to acquire RCM businesses with and without
software and, improve their profitability by increasing revenues
and operating efficiencies using our software, and in time,
commercializing the Syncordia Cloud, our cloud-based software
offering, to provide customer demanded turn-key solutions from a
single provider and to address compelling RCM market
opportunities.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
The following is a reconciliation of EBITDA with net loss and
comprehensive loss:
(in thousands of US Dollars)
|
Three Months
ended
|
Twelve Months
ended
|
|
Mar
31
2016
|
|
Mar
31
2015
|
Mar
31
2016
|
Mar
31
2015
|
Net loss and comprehensive
loss
|
(1,186)
|
|
(1,055)
|
(3,115)
|
(2,895)
|
Amortization of operating
and other
assets
|
809
|
|
642
|
3,084
|
1,082
|
Interest
expense
|
477
|
|
414
|
1,874
|
675
|
Income tax expense
(recovery)
|
(391)
|
|
-
|
(391)
|
-
|
EBITDA
|
(291)
|
|
1
|
1,452
|
(1,138)
|
The following is a reconciliation of Adjusted EBITDA and
Adjusted EBITDA before Corporate costs with Net
loss and comprehensive loss:
(in thousands of US Dollars)
|
|
|
|
Three Months
ended
|
Twelve Months
ended
|
|
Mar
31
2016
|
Mar
31
2015
|
Mar
31
2016
|
Mar
31
2015
|
Net loss and comprehensive
loss
|
(1,186)
|
(1,055)
|
(3,115)
|
(2,895)
|
Amortization of operating
and other
assets
|
809
|
642
|
3,084
|
1,082
|
Interest
expense
|
477
|
414
|
1,874
|
261
|
Income tax expense
(recovery)
|
(391)
|
-
|
(391)
|
-
|
Transaction
costs
|
160
|
4
|
1,874
|
822
|
Foreign exchange (gains)
and
losses
|
(3)
|
-
|
143
|
-
|
Unrealized (gains) and
losses on derivative financial
liability
|
(1)
|
-
|
(609)
|
-
|
Realized gain on contingent
consideration
|
-
|
-
|
(1,111)
|
-
|
Stock based
compensation
|
15
|
15
|
90
|
28
|
Adjusted EBITDA
(i)
|
(120)
|
21
|
1,911
|
(288)
|
Syncordia Cloud costs
(i)
|
371
|
158
|
1,485
|
265
|
Corporate costs
(i)
|
555
|
701
|
2,359
|
1,577
|
Adjusted EBITDA before
Syncordia Cloud and
Corporate costs
(i)
|
806
|
880
|
5,755
|
1,554
|
Notes:
|
|
|
(i)
|
|
Non-IFRS measure, Syncordia Cloud and Corporate
costs exclude stock based compensation, transaction costs,
foreign exchange gains and loss, fair value adjustments, and
amortization.
|
Syncordia Technologies and Healthcare Solutions,
Corp.
Consolidated Statements of Financial Position
As at March 31, 2016 and 2015
|
|
|
|
March
31
2016
|
March
31
2015
|
|
|
|
Assets
|
|
|
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
4,436,844
|
2,842,413
|
|
Accounts
receivable
|
2,226,715
|
1,931,076
|
|
Other
assets
|
377,185
|
145,304
|
|
|
|
|
7,040,744
|
4,918,793
|
|
|
|
Property and
equipment
|
338,622
|
168,418
|
|
|
|
Intangible
assets
|
22,694,613
|
16,134,626
|
|
|
|
Goodwill
|
10,781,769
|
5,836,719
|
|
|
|
|
40,855,748
|
27,058,556
|
|
|
|
Liabilities
|
|
|
|
|
|
Current
liabilities
|
|
|
|
Accounts payable and
accrued
liabilities
|
1,584,735
|
1,135,379
|
|
Holdback
payable
|
250,000
|
-
|
|
Contingent consideration
payable
|
-
|
2,320,000
|
|
Current portion of notes
payable
|
2,222,065
|
-
|
|
|
|
|
4,056,800
|
3,455,379
|
|
|
|
Notes
payable
|
12,350,631
|
10,483,989
|
|
|
|
Deferred tax
liabilities
|
1,932,097
|
-
|
|
|
|
Other non-current
liabilities
|
133,076
|
-
|
|
|
|
|
18,472,604
|
13,939,368
|
|
|
|
Shareholders'
Equity
|
|
|
|
|
|
Share
capital
|
25,517,330
|
14,387,095
|
|
|
|
Contributed
surplus
|
1,963,529
|
1,626,593
|
|
|
|
Deficit
|
(6,010,506)
|
(2,894,500)
|
|
Equity attributable to
shareholders of
Syncordia
|
21,470,353
|
13,119,188
|
|
Non-controlling
interests
|
912,791
|
-
|
|
22,383,144
|
13,119,188
|
|
|
|
|
40,855,748
|
27,058,556
|
Syncordia Technologies and Healthcare Solutions,
Corp.
Consolidated Statements of Loss and Comprehensive Loss
For the three and twelve months ended March
31, 2016 and 2015
|
|
|
|
Three months
ended March
31
|
Year
Ended March
31
|
|
2016
|
2015
|
2016
|
2015
|
|
|
|
|
|
Revenue
|
2,918,361
|
2,701,260
|
13,888,294
|
4,391,812
|
|
|
|
|
|
Gain on settlement of
contingent
consideration
|
-
|
-
|
1,111,342
|
-
|
|
2,918,361
|
2,701,260
|
14,999,636
|
4,391,812
|
|
|
|
|
|
Cost of
sales
|
1,024,050
|
957,678
|
4,112,376
|
1,507,654
|
|
|
|
|
|
Amortization of
operating
assets
|
715,077
|
568,577
|
2,792,428
|
962,670
|
|
1,179,234
|
1,175,005
|
8,094,832
|
1,921,488
|
|
|
|
|
|
Operating
expenses
|
2,025,767
|
1,736,446
|
8,098,383
|
3,199,442
|
|
|
|
|
|
Transaction
costs
|
159,839
|
4,255
|
1,946,009
|
821,805
|
|
|
|
|
|
Other
amortization
|
94,380
|
73,822
|
291,998
|
119,524
|
|
|
|
|
|
Loss before financing
expenses and
tax
|
(1,100,752)
|
(639,518)
|
(2,241,558)
|
(2,219,283)
|
|
|
|
|
|
Change in fair value of
derivative
liability
|
-
|
-
|
(608,987)
|
-
|
|
|
|
|
|
Interest
expense
|
476,676
|
414,295
|
1,873,913
|
675,217
|
|
|
|
|
|
Net loss before
tax
|
(1,577,428)
|
(1,053,813)
|
(3,506,484)
|
(2,894,500)
|
|
|
|
|
|
Income tax expense
(recovery)
|
(391,139)
|
-
|
(391,139)
|
-
|
|
|
|
|
|
Net Loss and
comprehensive loss for the
period
|
(1,186,289)
|
(1,053,813)
|
(3,115,345)
|
(2,984,500)
|
|
|
|
|
|
Net loss and
comprehensive loss attributable
to:
|
|
|
|
|
|
Shareholders of
Syncordia
|
(1,186,950)
|
(1,053,813)
|
(3,116,006)
|
(2,894,500)
|
|
Non-controlling
interests
|
661
|
-
|
661
|
-
|
|
|
|
|
|
|
|
|
|
|
Net loss per
share
|
|
|
|
|
|
Basic and diluted earnings
per
share
|
(0.06)
|
(0.07)
|
(0.17)
|
(0.33)
|
|
|
|
|
|
Weighted average number
of shares
outstanding
|
|
|
|
|
|
Basic
|
19,643,635
|
14,218,663
|
18,627,314
|
8,869,404
|
|
Diluted
|
19,672,056
|
14,243,041
|
18,655,735
|
8,893,782
|
Syncordia Technologies and Healthcare Solutions,
Corp.
Consolidated Statements of Cash Flows
For the three and twelve month periods ended March 31, 2016 and 2015
|
|
|
|
Three months
ended March
31
|
Twelve months
ended
March
31
|
|
2016
|
2015
|
2016
|
2015
|
|
|
|
|
|
Cash provided by (used
in)
|
|
|
|
|
|
|
|
|
|
Operating
activities
|
|
|
|
|
Net loss for the
period
|
(1,186,289)
|
(1,053,813)
|
(3,115,345)
|
(2,894,500)
|
Items not affecting
cash
|
|
|
|
|
|
Gain on settlement of
contingent
consideration
|
-
|
-
|
(1,111,342)
|
-
|
|
Reverse Takeover
transaction
costs
|
-
|
-
|
1,068,920
|
-
|
|
(Gain)/loss on derivative
liability
|
-
|
-
|
(608,987)
|
-
|
|
Income tax expense
(recovery)
|
(450,563)
|
-
|
(450,563)
|
-
|
|
Amortization
|
809,457
|
642,400
|
3,084,426
|
1,082,194
|
|
Non-cash interest on notes
payable
|
169,950
|
147,322
|
670,311
|
239,612
|
|
Share-based compensation
and
awards
|
14,598
|
14,026
|
89,837
|
27,524
|
Changes in non-cash working
capital
items
|
|
|
|
|
|
Accounts
receivable
|
448,996
|
(395,019)
|
778,683
|
(878,900)
|
|
Other
assets
|
107,646
|
17,674
|
(72,614)
|
(51,769)
|
|
Accounts payable and
accrued
liabilities
|
103,775
|
161,875
|
(234,432)
|
644,606
|
|
Other non-current
liabilities
|
5,648
|
-
|
133,077
|
-
|
|
23,218
|
(465,535)
|
231,973
|
(1,831,233)
|
|
|
|
|
|
Investing
activities
|
|
|
|
|
Purchase of property,
equipment and intangible
assets
|
(13,302)
|
(71,303)
|
(171,797)
|
(102,056)
|
Acquisition of Health
Services
Integration
|
-
|
-
|
-
|
(21,413,474)
|
Acquisition of
Paragon
|
-
|
-
|
(3,479,929)
|
-
|
Acquisition of Billing
Solutions
|
(5,858,091)
|
-
|
(5,858,091)
|
-
|
Settlement of Paragon
holdback
|
-
|
-
|
(250,000)
|
-
|
Settlement of contingent
consideration
|
-
|
-
|
(1,208,658)
|
-
|
|
(5,871,393)
|
(71,303)
|
(10,968,475)
|
(21,515,530)
|
|
|
|
|
|
Financing
activities
|
|
|
|
|
Issuance of Class A
preferred
shares
|
-
|
-
|
-
|
3,500,000
|
Issuance of Class B Series
2 preferred
shares
|
-
|
100,000
|
3,405,000
|
12,281,442
|
Issuance of private
placement
|
-
|
-
|
8,052,460
|
-
|
Cash consideration from
issuance of Reverse Takeover
shares
|
-
|
-
|
402,605
|
-
|
Share issuance
costs
|
-
|
312
|
(831,560)
|
(867,342)
|
Proceeds from long-term
notes
|
-
|
-
|
1,332,388
|
12,000,000
|
Deferred financing
costs
|
-
|
-
|
(29,960)
|
(725,237)
|
|
-
|
100,312
|
12,330,933
|
26,1898,173
|
|
|
|
|
|
Increase/(decrease) in
cash and cash equivalents
during the
period
|
(5,848,175)
|
(436,526)
|
1,594,431
|
2,842,410
|
|
|
|
|
|
Cash and cash
equivalents - Beginning of
period
|
10,285,018
|
3,278,939
|
2,842,413
|
3
|
Cash and cash
equivalents - End of
period
|
4,436,844
|
2,842,413
|
4,436,844
|
2,482,413
|
|
|
|
|
|
Cash interest
paid
|
306,427
|
266,947
|
1,206,243
|
435,605
|
SOURCE Syncordia Technologies and Healthcare Solutions,
Corp.